WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA

WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA#WuXi #Biologics #Congratulates #Partner #CANbridge #Pharmaceuticals #Approval #Innovative #Velaglucerasebeta #Injection #Gaurunning #Gaucher #Disease #China #NMPA